MicroVention, Inc., a wholly owned subsidiary of Terumo Corp,, has inaugurated its new manufacturing facility in Coyol Free Zone in Alajuela.
The new plant represents MicroVention’s first manufacturing facility outside the United States and the first Neurovascular manufacturing facility in Costa Rica, the company said. Casa Presidencial said the investment was about $8 million.
This new facility will support the growth and expansion of products offered under the MicroVention and Terumo brand and the company is hiring approximately 150 persons with plans to expand in the coming months/years. The new facility is 7,500 square meters or 80,000 square feet and will encompass a 2,300 square meter clean room, about 25,000 square feet.
Approximately 12,000 people currently work in the Life Sciences Sector in Costa Rica with 41 medical device companies producing orthopedic, cardiovascular, women´s health devices, and medical supplies. MicroVention will be the first company specializing in the neurovascular segment in Costa Rica. MicroVention has been recruiting its first employees, specifically in the areas of engineering, quality, production and administration.
Tokyo‐based Terumo Corp.is one of the world’s leading medical device manufacturers with $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine. The company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.
MicroVention, Inc. is a U.S. subsidiary of Terumo Corp. with its corporate headquarters in Tustin, California, and other manufacturing and administrative facilities in Santa Ana and Aliso Viejo, California,